Hubungan antara Kadar 25(OH)D3 dan C-Peptida Berdasarkan Lama Sakit pada Anak dengan Diabetes Melitus Tipe 1
DOI:
https://doi.org/10.21776/ub.jkb.2018.030.01.6Keywords:
25(OH)D3, DM tipe 1, C-peptidaAbstract
Diabetes melitus (DM) tipe 1 menjadi masalah kesehatan di banyak negara, dengan keseluruhan peningkatan per tahun diperkirakan sebesar 3%. DM tipe 1 merupakan konsekuensi dari proses destruksi autoimun sel β pankreas. Ditemukan hubungan antara defisiensi vitamin D dengan DM tipe 1. Penelitian cross sectional ini dilakukan untuk melihat hubungan antara kadar 25(OH)D3 dan C-peptida berdasarkan lama sakit pada anak dengan DM tipe 1. Subjek penelitian adalah 26 anak dengan DM tipe 1, status vitamin D pada sampel penelitian didominasi dengan status vitamin D yang tidak normal sebanyak 16 orang (61,5%). Hasil penelitian menunjukkan kadar 25(OH)D3 yang lebih rendah pada kelompok dengan lama sakit ≤ 5 tahun dan secara statistik tidak didapatkan perbedaan kadar 25(OH)D3 yang bermakna antara kedua kelompok (p=0,403). Didapatkan kadar C-peptida yang lebih tinggi pada kelompok dengan lama sakit ≤ 5 tahun dan secara statistik tidak didapatkan perbedaan kadar C-peptida yang bermakna antara kedua kelompok (p=0,137). Hubungan yang tidak signifikan didapatkan antara kadar vitamin D dan kadar C-peptida pada anak DM tipe 1, dengan keeratan hubungan yang lemah dan dengan korelasi bernilai positif (p=0,069; r=0,363). Dari penelitian ini dapat disimpulkan bahwa pada anak dengan DM tipe 1 didapatkan kadar 25(OH)D3 dan kadar C-peptida yang rendah. Semakin lama anak menderita DM tipe 1 dan tidak mendapatkan terapi yang adekuat, maka akan semakin rendah kadar 25(OH)D3 dan kadar C-peptida.Downloads
References
Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, and Donaghue KC. Definition, Epidemiology, and Classification of Diabetes in Children and Adolescents. Pediatric Diabetes. 2014; 15(20): 4–17.
Batubara JRL, Tridjaja B, and Pulungan AB. Gambaran Diabetes Melitus Tipe 1. Sari Pediatri. 2012; 15(6): 57-62.
Cahyono HA. Gambaran Klinis dan Laboratoris Diabetes Melitus Tipe-1 pada Anak. Jurnal Kedokteran Brawijaya. 2011; 26(4): 195-198.
Rajashree R, Ravishankar MV, Kholkute SD, and Goudar SS. Type 1 Diabetes Mellitus: An Update. International Journal of Diabetes and Metabolism. 2012; 20(3): 37-42.
Jeker LT, Jourdan BJ, and Bluestone JA. Breakdown in Peripheral Tolerance in Type 1 Diabetes in Mice and Humans. Cold Spring Harbor Perspectives in Medicine. 2012; 2(3): 1-21.
Griz LHM, Bandeira F, Gabbay MAL, Dib SA, and de Carvalho EF. Vitamin D and Diabetes Mellitus: An Update. Arquivos Brasileiros de Endocrinologia and Metabologia. 2014; 58(1): 1-8.
Van Belle TL, Coppieters KT, and Von Herrath MG. Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies. Physiological Reviews. 2011; 91(1): 79-118.
Oram RA, Jones AG, Besser RE, et al. The Majority of Patients with Long-duration Type 1 Diabetes are Insulin Microsecretors and Have Functioning Beta Cells. Diabetologia. 2014; 57(1): 187-191.
Jones AG and Hattersley AT. The Clinical Utility of C-peptide Measurement in the Care of Patients with Diabetes. Diabetic Medicine. 2013; 30(7): 803-817.
Sastroasmoro S. Pemilihan Subjek Penelitian. Di dalam: Sastroasmoro S and S. Ismael (Eds). Dasar-dasar Metodologi Penelitian Klinis edisi 4. Jakarta: Sagung Seto; 2008: hal. 311.
Karavanaki K, Karanika E, Georga S, et al. Cytokine Respon to Diabetic Ketoacidosis in Children with Type 1 Diabetes. Endocrine Journal. 2011; 58(12): 1045-1053.
Alemzadeh R and Wyatt DT. Diabetes Mellitus in Children. In: Kliegman R, Stanton B, Geme J, and Schor N (Eds). Nelson Textbook of Pediatrics 15th edition. Philadelphia: Elsevier Saunders; 2007: pp. 1767–91.
American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 2016; 39(suppl.1): S13–S22.
Davis AK, DuBose SN, Haller MJ, et al. Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes. Diabetes Care. 2015; 38(3): 476–481.
Prietl B, Pilz S, Wolf M, et al. Vitamin D Supplementation and Regulatory T Cells in Apparently Healthy Subjects: Vitamin D Treatment for Autoimmune Diseases? The Israel Medicine Association Journal. 2010; 12(3): 136–139.
Kalyva E, Malakonaki E, Eiser C, and Mamoulakis D. Health-Related Quality of Life (HRQoL) of Children with Type 1 Diabetes Mellitus (T1DM): Self and Parental Perceptions. Pediatric Diabetes. 2011; 12(1): 34-40.
Pereira DA, Costa NMSC, Sousa ALL, Jardim PCBV, and Zanini CRO. The Effect of Educational Intervention on the Disease Knowledge of Diabetes Mellitus Patients. The Revista Latino-Americana de Enfermagem. 2012; 20(3): 478-485.
Hassanein MA and Sultan I. Evaluation of Nutrition and Health Status among Children with Diabetes. Life Science Journal. 2014; 11(2): 327-334.
Pulungan AB. Pubertas dan Gangguannya. In: Batubara JRL, Tridjaja B, and Pulungan AB (Eds). Buku Ajar Endokrinologi Anak edisi 1. Jakarta: Sagung Seto; 2010: hal. 85-120.
Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents from 2001 to 2009. Journal of the American Medical Association. 2014; 311(17): 1778-86.
Diaz-Valencia PA, Bougnères P, and Valleron AJ. Global Epidemiology of Type 1 Diabetes in Young Adults and Adults: A Systematic Review. BioMed Central Public Health. 2015; 15: 255-269.
Plamper M, Gohlke B, Woelfle J, et al. Interaction of Pubertal Development and Metabolic Control in Adolescents with Type 1 Diabetes Mellitus. Journal of Diabetes Research. 2017; 52: 1-8.
Himawan IW, Pulungan AB, Tridjaja B, and Batubara JRL. Komplikasi Jangka Panjang dan Jangka Pendek Diabetes Melitus Tipe 1. Sari Pediatri. 2009; 10(6): 367-372.
Wang L, Lovejoy NF, and Faustman DL. Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured with an Ultrasensitive C-peptide Assay. Diabetes Care. 2012; 35(3): 465–470.
Almeida MH, Dantas JR, Barone B, et al. Residual C-peptide in Patients with Type 1 Diabetes and Multiethnic Backgrounds. Clinics. 2013; 68(1): 123-126.
McGee P, Steffes M, Nowicki M, et al. Insulin Secretion Measured By Stimulated C-Peptide In Long-Established Type 1 Diabetes In The Diabetes Control And Complications Trial (DCCT)/ Epidemiology Of Diabetes Interventions And Complications (EDIC) Cohort: A Pilot Study. Diabetic Medicine. 2014; 31(10): 1264-1268.
Wahren J, Kallas A, and Sima AAF. The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes. Diabetes. 2012; 61(4): 761-772.
Balasubramanian S, Dhalanalaksmi K, and Amperayani S. Vitamin D Deficiency An Childhood–A Review of Current Guidelines on Diagnosis and Management. Indian Pediatrics. 2013; 50(7): 669-674.
Al-Agha AE and Ahmad IA. Association among Vitamin D Deficiency, Type 1 Diabetes Mellitus and Glycemic Control. Journal of Diabetes and Metabolism. 2015; 6(9): 594-598.
Janner M, Ballinari P, Mullis PE, and Fluck CE. High Prevalence of Vitamin D Deficiency in Children and Adolescent with Type 1 Diabetes. Swiss Medical Weekly. 2010; 140(7): 1-6.
Borkar V, Devidayal V, Verma S, and Bhalla AK. Low Levels of Vitamin D in North Indian Children with Newly Diagnosed Type 1 Diabetes. Pediatric Diabetes. 2010; 11(5): 345–350.
Greer S, Portelli L, Hung BS, et al. Serum Vitamin D Levels are Lower in Australian Children and Adolescents with Type 1 Diabetes than in Children without Diabetes. Pediatric Diabetes. 2013; 14(1): 31–41.
Svoren BM, Volkening LK, Wood JR, and Laffel LMB. Significant Vitamin D Deficiency in Youth with Type 1 Diabetes Mellitus. The Journal of Pediatrics. 2009; 154(1): 132-134.
Raab J, Giannopoulou EZ, Schneider S, et al. Prevalence of Vitamin D Deficiency in Pre-type 1 Diabetes and Its Association with Disease Progression. Diabetologia. 2014; 57(5): 902-908.
Ashrit P, Kalasker V, Rao S, and Bhat HK. Assessment of Vitamin D Status in Type 1 Diabetes Mellitus in Pediatric Age Group. International Journal of Clinical Biochemistry and Research. 2016; 3(3): 320-324.
Holick MF and Chen TC. Vitamin D Deficiency: A Worldwide Problem with Health Consequences. American Journal of Clinical Nutrition. 2008; 87(4): 1080S–1086S.
Bizzaro G, Antico A, Fortunato A, and Bizzaro N. Vitamin D and Autoimmune Diseases: Is Vitamin D Receptor (VDR) Polymorphism the Culprit? Israel Medical Association Journal. 2017; 19: 438-443.
Jeddi S, Syedmoradi L, Bagheripour F, and Ghasemi A. The Effects of Vitamin D on Insulin Release From Isolated Islets of Rats. International Journal of Endocrinology and Metabolism. 2015; 13(1): e20620.
Li X, Liao L, Yan X, et al. Protective Effects of 1-alpha-hydroxyvitamin D3 on Residual Beta-cell Function in Patients with Adult-onset Latent Autoimmune Diabetes (LADA). Diabetes/Metabolism Research and Review. 2009; 25(5): 411-416.
Chandler PD, Giovannucci EL, Scott JB, et al. Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months. Scientific Reports. 2014; 5(10411): 1-10.
Chakhtoura M and Azar ST. The Role of Vitamin D Deficiency in the Incidence, Progression, and Complications of Type 1 Diabetes Mellitus. International Journal of Endocrinology. 2013; 10(1155): 1-10.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
